CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference 2008, which is being held on October 7, 2008 in New York, NY. Curis’ presentation will take place on Tuesday, October 7th at 8:30 a.m. Eastern Daylight Time.
